专利检索 ap:("Andrey Alexandrovich Ivashchenko" OR "Vasilievich Ivashchenko" OR "Yan Vadimovich Lavrovsky" OR "Oleg Dmitrievich Mitkin" OR "Nikolay Filippovich Savchuk" OR "Sergey Yevgenievich Tkachenko" OR "Ilya Matusovich Okun") AND inv:"Nikolay Filippovich Savchuk" 第 5 页

41.

发明授权
Pharmaceutical combination therapy and prevention with aprotinin + nirmatrelvir of SARS-CoV-2 and/or disease associated with this infection, including COVID-19 有权

公开(公告)号：US11648300B1

公开(公告)日：2023-05-16

申请号：US17709727

申请日：2022-03-31

申请人： ASAVI LLC , Alexandre Vasilievich Ivachtchenko , Alena Alexandrovna Ivachtchenko , Nikolay Filippovich Savchuk

发明人： Alexandre Vasilievich Ivachtchenko , Andrey Alexandrovich Ivashchenko , Alena Alexandrovna Ivachtchenko , Ilya Andreevich Ivachtchenko , Nikolay Filippovich Savchuk

IPC分类号： A61K38/57 , A61P31/14 , A61K31/427 , A61K31/403

CPC分类号： A61K38/57 , A61K31/403 , A61K31/427 , A61P31/14

摘要： The present application relates to the new the pharmaceutical combination therapy and prevention of SARS-CoV-2 and/or disease associated with this infection, including viral and bacterial pneumonia and COVID-19, using aprotinin (APR), ribavirin and/or nirmatrelvir (NIMR), the pharmaceutical kit and the pharmaceutical composition for this pharmaceutical combination therapy and prevention of SARS-CoV-2 and/or disease associated with this infection, including COVID-19.